A Multicenter, Open-Label Study to Evaluate Fatigue in Subjects With Relapsing-Remitting Multiple Sclerosis During Treatment With Tecfidera (Dimethyl Fumarate) Gastro-Resistant Hard Capsules
Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2016
Price : $35 *
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms TECNERGY
- Sponsors Biogen
- 04 Sep 2015 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.
- 04 Sep 2015 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017 as reported by ClinicalTrials.gov.
- 04 Sep 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.